loadpatents
name:-0.049394845962524
name:-0.021764039993286
name:-0.0017240047454834
McClanahan; Terrill K. Patent Filings

McClanahan; Terrill K.

Patent Applications and Registrations

Patent applications and USPTO patent grants for McClanahan; Terrill K..The latest application filed is for "gene expression based biomarker of tumor response to pd-1 antagonists".

Company Profile
2.21.47
  • McClanahan; Terrill K. - Sunnyvale CA US
  • MCCLANAHAN; Terrill K. - Palo Alto CA US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
System and methods for deriving gene signature biomarkers of response to PD-1 antagonists
Grant 11,377,693 - Ayers , et al. July 5, 2
2022-07-05
Blood-based biomarkers of tumor sensitivity to PD-1 antagonists
Grant 11,326,211 - Ayers , et al. May 10, 2
2022-05-10
Gene Expression Based Biomarker Of Tumor Response To Pd-1 Antagonists
App 20220112564 - Loboda; Andrey ;   et al.
2022-04-14
Combination Therapy Of A Pd-1 Antagonist And Lag3 Antagonist For Treating Patients With Non-microsatellite Instability-high Or Proficient Mismatch Repair Colorectal Cancer
App 20210317214 - Chartash; Elliot K. ;   et al.
2021-10-14
System And Methods For Deriving Gene Signature Biomarkers Of Response To Pd-1 Antagonists
App 20180327848 - Ayers; Mark D. ;   et al.
2018-11-15
Blood-based Biomarkers Of Tumor Sensitivity To Pd-1 Antagonists
App 20180148790 - Ayers; Mark ;   et al.
2018-05-31
Biomarkers for TSLP treatment
Grant 9,732,151 - Beaumont , et al. August 15, 2
2017-08-15
Gene Signature Biomarkers Of Tumor Response To Pd-1 Antagonists
App 20160312295 - Ayers; Mark ;   et al.
2016-10-27
Pd-l1 Gene Signature Biomarkers Of Tumor Response To Pd-1 Antagonists
App 20160312297 - Ayers; Mark ;   et al.
2016-10-27
Ifn-gamma Gene Signature Biomarkers Of Tumor Response To Pd-1 Antagonists
App 20160304969 - Ayers; Mark ;   et al.
2016-10-20
Biomarkers For Tslp Treatment
App 20140302061 - Beaumont; Maribel ;   et al.
2014-10-09
Isolated Mammalian Monocyte Cell Genes; Related Reagents
App 20140141445 - Adema; Gosse Jan ;   et al.
2014-05-22
Isolated Mammalian Monocyte Cell Genes; Related Reagents
App 20140141444 - Adema; Gosse Jan ;   et al.
2014-05-22
Use of Cytokine Expression to Predict Skin Inflammation; Methods of Treatment
App 20140065147 - KASTELEIN; ROBERT A. ;   et al.
2014-03-06
Mammalian Genes; Related Reagents
App 20130203060 - Franz-Bacon; Karin ;   et al.
2013-08-08
Nucleic acids encoding TNF.gamma.
Grant 8,426,573 - Parham , et al. April 23, 2
2013-04-23
Methods of making antibodies specific for cysteine-rich soluble protein C23
Grant 8,415,460 - Franz-Bacon , et al. April 9, 2
2013-04-09
Isolated Mammalian Monocyte Cell Genes; Related Reagents
App 20130034561 - Adema; Gosse Jan ;   et al.
2013-02-07
Use Of Cytokine Expression To Predict Skin Inflammation; Methods Of Treatment
App 20120276105 - Kastelein; Robert A. ;   et al.
2012-11-01
Mammalian Genes; Related Reagents And Methods
App 20120164147 - Parham; Christi L. ;   et al.
2012-06-28
Method of treating skin inflammation
Grant 8,178,095 - Kastelein , et al. May 15, 2
2012-05-15
Nucleic acid encoding TNFx protein
Grant 8,148,507 - Parham , et al. April 3, 2
2012-04-03
Uses Of Il-23 Agonists And Antagonists; Related Reagents
App 20120034219 - Oft; Martin ;   et al.
2012-02-09
Isolated Mammalian Monocyte Cell Genes; Related Reagents
App 20120020990 - Adema; Gosse Jan ;   et al.
2012-01-26
Methods of inhibiting tumor growth using blocking antibodies to IL-23R
Grant 8,034,341 - Oft , et al. October 11, 2
2011-10-11
Antibodies that bind DNAX leukocyte associated immunoglobulin-like receptor
Grant 7,999,078 - Adema , et al. August 16, 2
2011-08-16
Mammalian Genes; Related Reagents And Methods
App 20110165165 - Parham; Christi L. ;   et al.
2011-07-07
Use of Cytokine Expression to Predict Skin Inflammation; Methods of Treatment
App 20100254991 - Kastelein; Robert A. ;   et al.
2010-10-07
Isolated Mammalian Monocyte Cell Genes; Related Reagents
App 20100209907 - Adema; Gosse Jan ;   et al.
2010-08-19
Method of treating skin inflammation
Grant 7,776,540 - Kastelein , et al. August 17, 2
2010-08-17
Method of treatment of skin inflammation
Grant 7,740,848 - Kastelein , et al. June 22, 2
2010-06-22
Mammalian Genes; Related Reagents And Methods
App 20100104576 - Parham; Christi L. ;   et al.
2010-04-29
Uses of IL-23 Agonists and Antagonists; Related Reagents
App 20100003251 - Oft; Martin ;   et al.
2010-01-07
Mammalian Genes; Related Reagents
App 20090252736 - Franz-Bacon; Karin ;   et al.
2009-10-08
Binding compounds specific for cysteine-rich soluble protein C23
Grant 7,560,533 - Franz-Bacon , et al. July 14, 2
2009-07-14
Mammalian Genes; Related Reagents And Methods
App 20090155242 - Parham; Christi L. ;   et al.
2009-06-18
Method of treating skin inflammation
Grant 7,501,247 - Kastelein , et al. March 10, 2
2009-03-10
Use of IL-17 Expression to Predict Skin Inflammation; Methods of Treatment
App 20090028860 - Kastelein; Robert A. ;   et al.
2009-01-29
C23 Polypeptides
Grant 7,482,426 - Franz-Bacon , et al. January 27, 2
2009-01-27
Use of Cytokine Expression to Predict Skin Inflammation; Methods of Treatment
App 20080317749 - Kastelein; Robert A. ;   et al.
2008-12-25
Method of evaluating inflammatory skin disorders using IL-17 and/or IL-19
Grant 7,427,402 - Kastelein , et al. September 23, 2
2008-09-23
Uses Of Il-23 Agonists And Antagonists; Related Reagents
App 20080057058 - Oft; Martin ;   et al.
2008-03-06
Uses of IL-23 agonists and antagonists; related reagents
Grant 7,282,204 - Oft , et al. October 16, 2
2007-10-16
Tumor Association Of Mdl-1 And Methods
App 20070237772 - MCCLANAHAN; TERRILL K. ;   et al.
2007-10-11
Use of cytokine expression to predict skin inflammation; methods of treatment
App 20070098727 - Kastelein; Robert A. ;   et al.
2007-05-03
Tumor association of MDL-1 and methods
App 20060099144 - McClanahan; Terrill K. ;   et al.
2006-05-11
Use of cytokine expression to predict skin inflammation; methods of treatment
App 20050287593 - Kastelein, Robert A. ;   et al.
2005-12-29
Antibodies that specifically bind to FDF03
App 20050287582 - Adema, Gosse Jan ;   et al.
2005-12-29
Use of IL-17 expression to predict skin inflammation; methods of treatment
App 20050244874 - Kastelein, Robert A. ;   et al.
2005-11-03
Methods of modulating cytokine activity; related reagents
App 20050214296 - Kastelein, Robert A. ;   et al.
2005-09-29
Mammalian genes; related reagents and methods
App 20050186620 - Parham, Christi L. ;   et al.
2005-08-25
Isolated mammalian monocyte cell genes; related reagents
App 20050059808 - Adema, Gosse Jan ;   et al.
2005-03-17
Isolated mammalian monocyte cell genes; related reagents
App 20040143858 - Adema, Gosse Jan ;   et al.
2004-07-22
Isolated mammalian monocyte cell genes; related reagents
App 20030105303 - Adema, Gosse Jan ;   et al.
2003-06-05
Mammalian genes; related reagents
App 20030092148 - Franz-Bacon, Karin ;   et al.
2003-05-15
Mammalian genes; related reagents
App 20030092123 - Franz-Bacon, Karin ;   et al.
2003-05-15
Antibodies that specifically bind DNAX leukocyte associated immunoglobulin-like receptor
Grant 6,479,638 - Adema , et al. November 12, 2
2002-11-12
Mammalian genes; related reagents and methods
App 20020142292 - Parham, Christi L. ;   et al.
2002-10-03
Mammalian genes; related reagents
App 20020111476 - Franz-Bacon, Karin ;   et al.
2002-08-15
Purified mammalian nucleobase permeases; nucleic acids; antibodies
Grant 5,858,707 - Guimaraes , et al. January 12, 1
1999-01-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed